Structure of the intact PPAR-γ-RXR-α nuclear receptor complex on DNA

Nature

Volumn 456, Issue 7220, 2008, Pages 350-356

  Chandra, Vikas ^a   Huang, Pengxiang ^a   Hamuro, Yoshitomo ^b   Raghuram, Srilatha ^a   Wang, Yongjun ^c   Burris, Thomas P ^c   Rastinejad, Fraydoon ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^b ExSAR Corporation   (United States)

^c PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 CHLORO 5 NITROBENZANILIDE; ALITRETINOIN; BVT 13; CELL NUCLEUS RECEPTOR; DNA; HETERODIMER; HORMONE RECEPTOR STIMULATING AGENT; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; RETINOID X RECEPTOR ALPHA; ROSIGLITAZONE; UNCLASSIFIED DRUG;

CELL ORGANELLE; DNA; DRUG; GENE EXPRESSION; LIGAND; PEPTIDE; PROTEIN;

ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DNA BINDING; DNA BINDING MOTIF; DNA PROTEIN COMPLEX; DNA RESPONSIVE ELEMENT; DRUG RECEPTOR BINDING; DRUG TARGETING; GENE ACTIVATION; LIGAND BINDING; MOLECULAR DYNAMICS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN STRUCTURE;

EID: 56749130032     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/nature07413     Document Type: Article

References (48)

1. Nagy, L. &Schwabe, J. W. Mechanism of the nuclear receptor molecular switch. Trends Biochem. Sci. 29, 317-324 (2004).
2. Sonoda, J., Pei, L. &Evans, R. M. Nuclear receptors: decoding metabolic disease. FEBS Lett. 582, 2-9(2008).
3. Raghuram, S. et al. Identification of heme as the ligand for the orphan nuclear receptors REV-ERBa and REV-ERBp. Nature Struct. Mol. Biol. 14, 1207-1213 (2007).
4. Yin, L. et al. Rev-erba, a heme sensor that coordinates metabolic and circadian pathways. Science 318, 1786-1789 (2007).
5. Bain, D. L., Heneghan, A. F., Connaghan-Jones, K. D. &Miura, M. T. Nuclear receptor structure: implications for function. Annu. Rev. Physiol. 69, 201-220 (2007).
6. Khorasanizadeh, S. &Rastinejad, F. Nuclear-receptor interactions on DNA-response elements. Trends Biochem. Sci. 26, 384-390 (2001).
7. Wurtz, J. M. et al. A canonical structure for the ligand-binding domain of nuclear receptors. Nature Struct. Biol. 3, 87-94 (1996).
8. Mc Kenna, N. J. &O'Malley, B. W. Combinatorial control of gene expression by nuclear receptors and coregulators. Cell 108, 465-474 (2002).
9. Heery, D. M., Kalkhoven, E., Hoare, S. &Parker, M. G. A signature motif in transcriptional co-activators mediates binding to nuclear receptors. Nature 387, 733-736 (1997).
10. Li, Y., Lambert, M. H. &Xu, H. E. Activation of nuclear receptors: a perspective from structural genomics. Structure 11, 741-746 (2003).
11. Greschik, H. &Moras, D. Structure-activity relationship ofnuclear receptor-ligand interactions. Curr. Top. Med. Chem. 3, 1573-1599 (2003).
12. Rastinejad, F. Retinoid X receptor and its partners in the nuclear receptor family. Curr. Opin. Struct. Biol. 11, 33-38 (2001).
13. Chawla, A., Repa, J. J., Evans, R. M. &Mangelsdorf, D. J. Nuclear receptors and lipid physiology: opening the X-files. Science 294, 1866-1870 (2001).
14. Chen, F., Law, S. W. &O'Malley, B. W. Identification of two mPPAR related receptors and evidence for the existence of five subfamily members. Biochem. Biophys. Res. Commun. 196, 671-677 (1993).
15. Lazar, M. A. PPARy, 10 years later. Biochimie 87, 9-13 (2005).
16. Lehrke, M. &Lazar, M. A. The many faces of PPARy. Cell 123, 993-999 (2005).
17. Lehmann, J. M. et al. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor y (PPARy). J. Biol. Chem. 270, 12953-12956 (1995).
18. Olefsky, J. M. &Saltiel, A. R. PPARy and the treatmentofinsulin resistance. Trends Endocrinol. Metab. 11, 362-368 (2000).
19. Staels, B. PPAR agonists and the metabolic syndrome. Therapie 62, 319-326 (2007).
20. Willson, T. M. et al. The structure-activity relationship between peroxisome proliferator-activated receptor y agonism and the antihyperglycemic activity of thiazolidinediones. J. Med. Chem. 39, 665-668 (1996).
21. Berger, J. &Wagner, J. A. Physiological and therapeutic roles of peroxisome proliferator-activated receptors. Diabetes Technol. Ther. 4, 163-174 (2002).
22. Bruning, J. B. et al. Partial agonists activate PPARy using a helix 12 independent mechanism. Structure 15, 1258-1271 (2007).
23. Leesnitzer, L. M. et al. Functional consequences of cysteine modification in the ligand binding sites of peroxisome proliferator activated receptors by GW9662. Biochemistry 41, 6640-6650 (2002).
24. Gampe, R. T. Jr etal. Asymmetry in the PPARy/RXRa crystal structure reveals the molecular basis of heterodimerization among nuclear receptors. Mol. Cell 5, 545-555 (2000).
25. Rastinejad, F., Perlmann, T., Evans, R. M. &Sigler, P. B. Structural determinants of nuclear receptor assembly on DNA direct repeats. Nature 375, 203-211 (1995).
26. Zhao, Q., Khorasanizadeh, S., Miyoshi, Y., Lazar, M. A. &Rastinejad, F. Structural elements of an orphan nuclear receptor-DNA complex. Mol. Cell 1, 849-861 (1998).
27. Ijpenberg, A., Jeannin, E., Wahli, W. &Desvergne, B. Polarity and specific sequence requirements of peroxisome proliferator-activated receptor (PPAR)/retinoid X receptor heterodimerbindingto DNA. A functional analysisofthe malic enzyme gene PPAR response element. J. Biol. Chem. 272, 20108-20117 (1997).
28. Rastinejad, F., Wagner, T., Zhao, Q. &Khorasanizadeh, S. Structure of the RXR-RAR DNA-binding complex on the retinoic acid response element DR1. EMBO J. 19, 1045-1054 (2000).
29. Sierk, M. L., Zhao, Q. &Rastinejad, F. DNA deformability as a recognition feature in the reverb response element. Biochemistry 40, 12833-12843 (2001).
30. Ozers, M. S. et al. Equilibrium binding of estrogen receptor with DNA using fluorescence anisotropy. J. Biol. Chem. 272, 30405-30411 (1997).
31. Desvergne, B. &Wahli, W. Peroxisome proliferator-activated receptors: nuclear control of metabolism. Endocr. Rev. 20, 649-688 (1999).
32. Kurokawa, R. et al. Regulation of retinoid signalling by receptor polarity and allosteric control of ligand binding. Nature 371, 528-531 (1994).
33. Werman, A. et al. Ligand-independent activation domain in the N terminus of peroxisome proliferator-activated receptor y (PPARy). Differential activity of PPARy-1 and -2 isoforms and influence of insulin. J. Biol. Chem. 272, 20230-20235 (1997).
34. Adams, M., Reginato, M. J., Shao, D., Lazar, M. A. &Chatterjee, V. K. Transcriptional activation by peroxisome proliferator-activated receptorgamma is inhibited by phosphorylation at a consensus mitogen-activated protein kinase site. J. Biol. Chem. 272, 5128-5132 (1997).
35. Castillo, G. et al. An adipogenic cofactor bound by the differentiation domain of PPARy. EMBOJ. 18, 3676-3687 (1999).
36. Shao, D. et al. Interdomain communication regulating ligand binding by PPAR-y. Nature 396, 377-380 (1998).
37. Maier, C. S. &Deinzer, M. L. Protein conformations, interactions, and H/D exchange. Methods Enzymol. 402, 312-360 (2005).
38. Hamuro, Y. et al. Rapid analysis of protein structure and dynamics by hydrogen/deuterium exchange mass spectrometry. J. Biomol. Tech. 14, 171-182 (2003).
39. Schulman, I. G., Li, C., Schwabe, J. W. &Evans, R. M. The phantom ligand effect: allosteric control of transcription by the retinoid X receptor. Genes Dev. 11, 299-308 (1997).
40. Germain, P., Iyer, J., Zechel, C. &Gronemeyer, H. Co-regulator recruitment and the mechanism of retinoic acid receptor synergy. Nature 415, 187-192 (2002).
41. Nolte, R. T. et al. Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-y. Nature 395, 137-143 (1998).
42. Minor, W., Cymborowski, M., Otwinowski, Z. &Chruszcz, M. HKL-3000: the integration of data reduction and structure solution-from diffraction images to an initial model in minutes. Acta Crystallogr. D 62, 859-866 (2006).
43. Murshudov, G. N., Vagin, A. A. &Dodson, E. J. Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr. D 53, 240-255 (1997).
44. Collaborative Computational Project, Number 4. The CCP4 suite: programs for protein crystallography. Acta Crystallogr. D 50, 760-763 (1994).
45. Brunger, A. T. Version 1.2 ofthe Crystallography and NMRsystem. Nature Protoc. 2, 2728-2733 (2007).
46. Mc Coy, A. J. Solving structures of protein complexes by molecular replacement with Phaser. Acta Crystallogr. D 63, 32-41 (2007).
47. Hamuro, Y. et al. Hydrogen/deuterium-exchange (H/D-Ex) of PPARy LBD in the presence of various modulators. Protein Sci. 15, 1-10 (2006).
48. Zhang, Z. &Smith, D. L. Determination of amide hydrogen exchange by mass spectrometry: a new tool for protein structure elucidation. Protein Sci. 2, 522-531 (1993).